These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11571432)

  • 21. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
    Wang M; Liu S; Ouyang N; Song E; Lutz J; Heemann U
    Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity.
    Brinkmann V; Lynch KR
    Curr Opin Immunol; 2002 Oct; 14(5):569-75. PubMed ID: 12183155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.
    Liu L; Wang C; He X; Shang W; Bi Y; Wang D
    Microsurgery; 2007; 27(4):300-4. PubMed ID: 17477424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival.
    Yin N; Zhang N; Xu J; Shi Q; Ding Y; Bromberg JS
    Transplantation; 2011 Jul; 92(1):25-30. PubMed ID: 21508896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
    J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K; Yanagawa Y; Masubuchi Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
    J Immunol; 1998 May; 160(10):5037-44. PubMed ID: 9590253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft.
    Zhang L; Zhu T; Sun EW; Shen SQ; Min ZL; Chen ZK
    Transplant Proc; 2003 Feb; 35(1):567-8. PubMed ID: 12591534
    [No Abstract]   [Full Text] [Related]  

  • 28. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model.
    Zhang J; Song Z; Wijkström M; Bari S; Sundberg B; Nava S; Groth CG; Korsgren O; Wennberg L
    Transplant Proc; 2000 Aug; 32(5):1017. PubMed ID: 10936327
    [No Abstract]   [Full Text] [Related]  

  • 31. Blocking lymphocyte trafficking with FTY720 prevents inflammation-sensitized hypoxic-ischemic brain injury in newborns.
    Yang D; Sun YY; Bhaumik SK; Li Y; Baumann JM; Lin X; Zhang Y; Lin SH; Dunn RS; Liu CY; Shie FS; Lee YH; Wills-Karp M; Chougnet CA; Kallapur SG; Lewkowich IP; Lindquist DM; Murali-Krishna K; Kuan CY
    J Neurosci; 2014 Dec; 34(49):16467-81. PubMed ID: 25471584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice.
    Luo ZJ; Tanaka T; Kimura F; Miyasaka M
    Immunopharmacology; 1999 Apr; 41(3):199-207. PubMed ID: 10428648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a new immunosuppressant, FTY720, on joint allografts.
    Watanabe H; Hamada Y; Toshima T; Nagasawa K; Sakano Y
    J Reconstr Microsurg; 1999 May; 15(4):295-8. PubMed ID: 10363553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
    Yuzawa K; Stephkowski SM; Wang M; Kahan BD
    Transplant Proc; 2000 Mar; 32(2):269. PubMed ID: 10715413
    [No Abstract]   [Full Text] [Related]  

  • 35. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.
    Zemann B; Kinzel B; Müller M; Reuschel R; Mechtcheriakova D; Urtz N; Bornancin F; Baumruker T; Billich A
    Blood; 2006 Feb; 107(4):1454-8. PubMed ID: 16223773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rescuing acute rejection of rat cardiac allografts with FTY720.
    Chueh SC; Tsai CC; Chiu B; Li YC; Lai MK
    Transplant Proc; 2000 Nov; 32(7):1629-30. PubMed ID: 11119868
    [No Abstract]   [Full Text] [Related]  

  • 37. A new immunosuppressant, FTY720, prolongs limb allograft survival in rats.
    Muramatsu K; Doi K; Shigetomi M; Kido K; Kawai S
    Ann Plast Surg; 1998 Feb; 40(2):160-5. PubMed ID: 9495465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival.
    Yanagawa Y; Hoshino Y; Chiba K
    Int J Immunopharmacol; 2000 Aug; 22(8):597-602. PubMed ID: 10988354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.
    Li XK; Tamura A; Fujino M; Guo L; Kakefuda T; Funeshima N; Enosawa S; Amari M; Naoe S; Amemiya H; Suzuki S
    Clin Exp Immunol; 2001 Feb; 123(2):331-9. PubMed ID: 11207666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of FTY720 on rat small bowel transplantation.
    Fujishiro J; Inoue S; Shimizu H; Yoshino H; Murakami T; Kobayashi E
    Transplantation; 2004 Jun; 77(12):1910-1. PubMed ID: 15223918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.